Aevi Genomic Medicine Inc (GNMX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

435 DEVON PARK DRIVE, WAYNE, PA 19087

iShares Barclays GNMA Bond Fund ETF is an exchange-traded index fund or Index ETF which is a separate investment portfolio of the iShares Trust, an open-end investment management company.

Data as of 2019-12-02 19:48:07 -0500
Market Cap8.005 Million Shares Outstanding64.767 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-0.296
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low1.3 / 0.11 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from GNMX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GNMX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GNMX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COLA MICHAEL F CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
175,746 2020-06-09 0

CLEMOW ALASTAIR J

  • Director
No longer subject to file 2020-02-03 0

NEIL GARRY ARTHUR CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2020-02-03 0

BARER SOL J

  • Director
No longer subject to file 2020-02-03 0

GRANO JOSEPH J JR

  • Director
No longer subject to file 2020-02-03 0

BAUER EUGENE A

  • Director
No longer subject to file 2020-02-03 0

DUNCAN BARBARA GAYLE

  • Director
No longer subject to file 2020-02-03 0

CHILDREN'S HOSPITAL OF PHILADELPHIA FOUNDATION

  • 10% Owner
No longer subject to file 2020-02-03 0

BAYLEY MATTHEW D

  • Director
No longer subject to file 2020-02-03 0

MCINAW MICHAEL INTERIM CFO

  • Officer
No longer subject to file 2020-02-03 0

ASTRAZENECA PLC

MEDIMMUNE LTD

  • 10% Owner
12,946,900 2019-12-19 0

PIPER BRIAN CFO & CORPORATE SECRETARY

  • Officer
0 2018-06-14 0

GANTZ WILBUR H

  • Director
71,073 2017-10-17 0

HARPER PHILIP R

  • 10% Owner
5,179,819 2017-09-01 0

APPLEBAUM SCOTT CHIEF LEGAL OFFICER

  • Officer
0 2016-04-15 0

BLECH ISAAC

  • Director
0 2016-04-15 0

MCMURRAY STEPHEN D

  • Director
0 2015-02-18 0

KANTER JOEL S

  • Director
0 2015-02-18 0

LEAMAN JOHN HAROLD CHIEF FINANCIAL OFFICER

  • Officer
0 2015-02-18 0

PEARLMAN ANDREW PRESIDENT AND CEO

  • Officer
  • Director
0 2011-09-22 0

BRUKARDT GARY A

  • Director
66,077 2011-09-07 0

DELLIO CLARENCE L CHIEF OPERATING OFFICER

  • Officer
0 2011-07-01 0

STERN BARUCH CHIEF SCIENTIFIC OFFICER

  • Officer
29,726 2011-05-11 0

ESTATE OF LORD LEONARD STEINBERG

  • 10% Owner
606,555 2011-04-13 0

KANTER JOSHUA

  • 10% Owner
636,975 2011-04-13 0

CHICAGO INVESTMENTS INC

  • 10% Owner
636,975 2011-04-13 0

BLECH ISAAC

RIVER CHARITABLE REMAINDER UNITRUST F/B/O ISAAC BLECH

LIBERTY CHARITABLE REMAINDER TRUST F/B/O ISAAC BLECH

WEST CHARITABLE REMAINDER UNITRUST

  • 10% Owner
  • SEE FOOTNOTE 3SEE FOOTNOTE 3
2,644,053 2011-04-13 0

RIVER CHARITABLE REMAINDER UNITRUST F/B/O ISAAC BLECH

  • 10% Owner
0 2011-04-07 0

BELLIN PHYLLIS K. SEE REMARKS

  • Officer
10,664 2011-04-07 0

BELLOMO STEPHEN CHIEF OPERATING OFFICER

  • Officer
0 2011-04-07 0

RIVER CHARITABLE REMAINDER UNITRUST F/B/O ISAAC BLECH

BLECH ISAAC

  • 10% Owner
0 2011-04-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments